Strategies to revitalize tail-end pharma brands include assessing brand position, optimizing P&L, SKU rationalization, and expanding into rural markets via tailored distribution and stakeholder engagement for growth.

Unlock growth in underleveraged pharma brands by optimizing portfolios, refreshing value propositions, targeting extra-urban markets via hub-and-spoke models, enhancing field force productivity, and leveraging digital strategies.